INTRODUCTION
Multimeric fibronectin is a major constituent of extracellular matrices found throughout the body, where it mediates a variety of adhesive and migratory events associated with tissue repair, neovascularization and embryogenesis. The major functional form of fibronectin in i o is the multimeric fibrillar form that is found in extracellular matrices [1] [2] [3] . In vivo studies have shown that inhibiting the interaction of mesodermal cells with fibronectin fibrils in amphibian embryos inhibits cell adhesion and migration and blocks gastrulation [4] . Recent studies with transgenic mice have shown that mice lacking fibronectin die in embryogenesis, emphasizing that fibronectin is essential for normal development [5] .
Polymerization of fibronectin into the extracellular matrix is thought to be tightly regulated in order to insure that matrix is appropriately deposited. Altered deposition of matrix molecules, including fibronectin, has been associated with such pathological events as cancer, atherosclerosis and fibrosis [2, [6] [7] [8] [9] . Deposition of fibronectin in the extracellular matrix is a cell-mediated process that involves the binding of soluble fibronectin to specific sites on the surface of substrate-attached cells, termed matrix assembly sites. Although advances have been made in understanding how fibronectin is deposited in the extracellular matrix, many questions remain unresolved.
Most of the fibronectin molecule is comprised of a series of repeating modules, termed types I, II and III [10] . Binding of soluble fibronectin to the surface of adherent cells is mediated by the N-terminal 70 kDa portion of the molecule. This binding is Abbreviations used : III 1 , first type III module of fibronectin ; DMEM, Dulbecco's modified Eagle medium ; AcNPV, Autographa californica nuclear polyhedrosis virus ; FBS, fetal-bovine serum ; FITC, fluorescein isothiocyanate ; 70K∆I [1] [2] [3] (etc.), 70 kDa deletion mutant lacking the first three type I modules ; GST-III 1-2 , glutathione S-transferase-III 1-2 fusion protein ; LDL, low-density lipoprotein.
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assays ; proteins lacking I % and I & did not bind. N-terminal molecules containing the fourth and fifth type I modules also bound to fibroblasts, suggesting that III " -like binding sites are present on the cell surface. However, the high-affinity binding sites on fibroblasts for fibronectin or the 70 kDa protein displayed more complex determinants, inasmuch as 70 kDa deletion mutants lacking I % and I & also bound to the cell surface, and deletion mutants lacking I " -$ and I % are important for cell-surface-mediated fibronectin polymerization.
non-co-operative and to a single class of binding sites that can be up-regulated and down-regulated by addition or withdrawal of lysophosphatidic acid [11] or phorbol esters [12] . Binding of the 70 kDa fragment has been localized primarily to the 27 kDa Nterminal portion [13, 14] , which contains five type I modules. The presence of excess 70 kDa fragment blocks the binding of intact fibronectin to cells and thereby inhibits fibronectin matrix assembly [13, 14] . Following the binding of fibronectin to the cell surface via the N-terminal 70 kDa region, interactions between fibronectin molecules leads to formation of fibronectin multimers. These multimers are insoluble in SDS and stabilized by disulphides [15] . Recently it has been shown that a dimeric form of the 70 kDa protein containing the 70 kDa N-terminal region of fibronectin directly linked to the C-terminal bridge region is assembled into disulphide-stabilized aggregates. Formation of SDS-insoluble complexes, however, required co-assembly with intact fibronectin [16] .
The site on the cell surface that mediates binding of the Nterminal portion of fibronectin has not been identified. It has been suggested that the α & β " integrin receptor serves as the matrix assembly receptor on cells, since antibodies to α & β " block assembly of fibronectin into the matrix [17, 18] . In addition, deposition of fibronectin into the matrix is modulated by the level of α & β " expression on cells [19] [20] [21] . However, direct binding of the 70 kDa N-terminal fragment of fibronectin to α & β " could not be demonstrated [3] . It has also been proposed that the III " module of fibronectin may serve as a binding site for the Nterminal region of fibronectin on the cell surface [22] . More recently, the integrin-binding III "! module of fibronectin has been shown to contain a conformation-dependent binding site for the III " module [23] . Binding of fibronectin to the α & β " integrin may alter the conformation of III "! and thus promote fibronectin-fibronectin interactions involving III " and the Nterminal region that lead to the self-assembly of fibronectin into the extracellular matrix [22] [23] [24] .
Several laboratories have demonstrated a role for III " in fibronectin matrix assembly [25, 26] . Monoclonal antibodies against the ninth type I (I * ) and the first type III modules (III " ) inhibit matrix assembly, but do not block binding of the 70 kDa fragment, suggesting a role for these regions in some step subsequent to initial cell-surface binding [25] . A proteolytically derived fibronectin fragment containing a portion of III " was shown to bind to fibronectin and block matrix assembly [26] . In addition, a recombinant III " fragment was demonstrated to promote fibronectin-fibronectin self-association in solution and on the cell surface [24] . Conformationally altered III "
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MATERIALS AND METHODS

Cells and viruses
The insect cell line IPLB-SF-21, adapted to grow in the serumfree medium SF900-II, was obtained from Life Technologies (Gaithersburg, MD, U.S.A.). TJ6F normal human foreskin fibroblasts were established by Dr. Lynn Allen Hoffmann (University of Wisconsin, Madison, WI, U.S.A.). These cells were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10 % fetal bovine serum (FBS).
Wild-type Autographa californica nuclear polyhedrosis virus (AcNPV) and the mutant AcNPV virus v∆35K\lacZ [29] were generously given by Dr. Paul Friesen (University of Wisconsin). Baculogold DNA was purchased from PharMingen (San Diego, CA, U.S.A.).
Production of recombinant baculoviruses
The recombinant baculovirus Fn571\AcNPV has been previously described [30] . This virus directs the expression of a recombinant 70 kDa protein (70 kDa). 70 kDa deletion mutants (formerly called ' Gap proteins ') were previously expressed in COS cells [28] . 70K∆I
, and the 40 kDa protein (70K∆I " -& ,Pro"*-His#%#). The recombinant 40 kDa protein contains tryptophan instead of valine at position 10. Trp"! is followed by four extra amino acids (Pro-Trp-Pro-Ser) not found in the wild-type sequence ; the wild-type sequence resumes at Ala"" [31] . Amino acids deleted from each mutant are shown in parentheses and are numbered from the N-terminal pyroglutamic acid in the processed protein [10] . Mutant DNAs were subcloned into the baculovirus expression vectors pAcYM1 [32] or pEV\35K (a gift from Dr. Paul Friesen). Recombinant viruses were generated according to established procedures [33, 34] . Viral stocks were prepared using SF21 cells grown in serum-free SF900-II medium.
Recombinant mutant and wild-type 70 kDa proteins
Supernatant from infected cells was collected either 48 or 72 h post-infection. Recombinant proteins were purified from the supernatant on columns of gelatin-agarose essentially as described [30] . Protein concentrations were calculated from their absorbance at 280 nM. The absorbance 0.1 % ( l 1g\l) of each protein was calculated from its amino acid composition using the computer program PHYSCHEM (IntelliGenetics, Mountain View, CA, U.S.A.). The absorbance 0.1 % ranged from 1.95 to 2.0 for 70 kDa and 70 kDa deletion mutants.
SF21 cells do not produce any identifiable or detectable endogenous fibronectin. Thus recombinant mutant or wild-type 70 kDa proteins produced by these cells do not contain any contaminating insect cell fibronectin.
Recombinant III 1 and glutathione S-transferase-III 1-2 fusion protein (GST-III 1-2 )
Recombinant III " was produced in bacteria and purified as described in [22] . To generate GST-III " -# , PCR was used to amplify human fibronectin cDNA encoding the first and second type III modules of fibronectin. The primers used were : 5h-CCCGGATCCAGTGGTCCTGTCGAAGTATT and 5h-CCC-GAATTCCTATGTTGTTTGTGAAGTAGACAGG.
PCRamplified DNA was cloned into the bacterial expression vector pGEX-2T (Pharmacia) and sequenced [35] to confirm that no base changes had been introduced during amplification of the DNA. DNA was transfected into DH5α bacteria and the GST-III " -# fusion protein purified from bacterial lysates on columns of glutathione-agarose as described for III " [22] .
SDS/PAGE
SDS\PAGE was performed as decsribed by Laemmli [36] .
Proteins were mixed with sample buffer (final concentration 1 % SDS\10 % glycerol\0.02 % Bromophenol Blue\50 mM Tris\HCl, pH 6.8\5 % β-mercaptoethanol) before being applied to 9 or 14 % slab gels. Proteins were revealed by staining with 0.05 % Coomassie Blue. Molecular-mass standards were purchased from Life Technologies.
Iodination of proteins
Mutant and wild-type 70 kDa proteins were iodinated using the chloramine- method as previously described [13] . Labelled proteins were separated from unincorporated iodine by gel filtration on Pharmacia PD-10 columns. Iodinated proteins were dialysed against TBS at room temperature for 3 h. The specific activities of iodinated proteins were :
44i10"" µCi\mol) and 70 kDa (2.09i10"" µCi\mol).
Binding assays
Binding assays were performed essentially as described [13] . Briefly, human fibroblasts were seeded at 8i10% cells\well into 12-well cluster dishes in DMEM containing 10 % FBS. Cells were allowed to grow to confluence for 3-5 days. Cells were washed three times with serum-free DMEM, then incubated with medium containing iodinated proteins. Equal molar amounts of "#&I-70 kDa protein and "#&I-deletion mutants were added to cells in DMEM containing 0.1 % BSA. Cells were incubated at 37 mC for the times indicated in the Figure legends. Following this incubation period, cells were washed three times in PBS, pH 7.4, then solubilized in 0.1 M NaOH and radioactivity was measured in a γ-radiation counter. Non-specific binding was determined by incubating cells in the presence of excess unlabelled recombinant rat 70 kDa protein (15-20 µg\ml ; 0.2-0.3 µM).
For competition experiments,"#&I-fibronectin or "#&I-70 kDa protein was incubated in the presence of various amounts of unlabelled 70 kDa or deletion mutants for 20 h at 37 mC. Bound proteins were processed as indicated above.
Solid-phase binding assay
Plates were coated with fibronectin or III " essentially as described [22] . III " was diluted to 2-10 µg\ml in PBS and then incubated at 90 mC for 10 min. III " was then added to 24-well plates and incubated for an additional 60 min at 80 mC. Plates were allowed to cool at 37 mC for 30 min, after which time unbound protein was removed and sites that had not reacted were blocked with 1 % BSA\PBS for 2 h at 37 mC. Plates were washed three times with PBS containing 0.1 % BSA, then incubated with 1.4 pmol of "#&I-proteins at 37 mC for 90 min. Plates were washed as described above, bound proteins were solubilized with 1 M NaOH and radioactivity was measured in a γ-radiation counter. Non-specific binding was determined by incubating iodinated proteins in the presence of excess unlabelled 70 kDa protein (15-20 µg\ml ; 0.2-0.3 µM). For competition experiments, "#&I-70K was incubated in the presence of various concentrations of unlabelled 70K∆I " -$ and 70K∆I % -& and wild-type 70 kDa proteins. For ELISA, various concentrations of III " were coated on to 96-well plates and processed as described above. Equal molar amounts (285 nM) of the 70 kDa protein or deletion mutants were added in PBS containing 0.2 % BSA and incubated for 90 min at 37 mC. Plates were washed three times with 0.2 % BSA\PBS, then incubated for 2 h at room temperature with a rabbit antiserum produced to recombinant 40 kDa protein (70K∆I " -& ) at 1 : 1500. Plates were washed three times with TBS containing 0.05 % Tween-20, then incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (Bio-Rad) at 1 : 6000 for 2 h at room temperature. After three washes with TBS\0.05 % Tween-20, plates were developed with 2,2h-azinobis-(3-ethylbenzthiazolinesulphonic acid) (Sigma) for 60 min at room temperature. Absorbance at 410 nm was read on a Bio-Kinetics EL312e Reader (Biotex Instruments, Winooski, VT, U.S.A.). The anti-(40 kDa protein) antibody was titred against the 70 kDa protein, the 40 kDa protein, and each of the deletion mutants using a direct ELISA. Half-maximal absorbance was obtained with an antibody dilution of 1 : 1500 for all of the proteins tested.
Indirect immunofluorescence
Human fibroblasts were seeded into 12-well cluster dishes on to 18 mm glass coverslips at 2.5i10& cells\well in DMEM containing 10 % fibronectin-depleted serum. Cells were seeded in the absence (control) or presence of 500 nM 70 kDa protein, 70K∆I
Cells were incubated for 25 h at 37 mC, and then incubated with a polyclonal antibody to human fibronectin at 1 : 1000 for 60 min at room temperature. After washing, cells were incubated with fluorescein-conjugated goat anti-rabbit IgG for 30 min. Cells were washed, mounted, then examined using an Olympus microscope equipped with epifluorescence.
Direct immunofluorescence 70 kDa protein, 70K∆I
" -$ and 70K∆I % -& were conjugated to fluorescein isothiocyanate (FITC ; Cappel, West Chester, PA, U.S.A.) or Texas Red sulphonyl chloride (Molecular Probes, Inc., Eugene, OR, U.S.A.) according to manufacturer's instructions. Unconjugated fluorochromes were removed using a PD10 gel-filtration column. Adherent fibroblasts were washed free of serum-containing medium and incubated in serum-free DMEM containing 0.4 % Redu-SerII (Upstate Biotechnology, Lake Placid, NY, U.S.A. ) and 20 µg\ml cycloheximide for 3 h. Cells were then trypsin-treated, washed three times with the above medium, and plated on to 18 mm-diameter round coverslips previously coated with 20 µg\ml fibronectin. Cells were seeded in serum-free DMEM containing 0.4 % Redu-SerII and 20 µg\ml cycloheximide and incubated overnight at 37 mC. The next day the medium was supplemented with fluorescently labelled proteins (70 nM) and incubated for 2 h at 37 mC. Cells were fixed with paraformaldehyde, permeabilized with 0.5 % Triton X-100 in Small's buffer [37] , mounted in p-phenylenediamine in Small's buffer and examined under an Olympus microscope. Figure 1A ) with deletions of one or several type I modules were expressed in insect cells using a baculovirus expression system ( Figure 1A ). After infection with recombinant viruses, conditioned media were isolated from SF21 cells, and 70 kDa and 70 kDa deletion mutants were purified by gelatin-agarose affinity chromatography and analysed by SDS\PAGE. The purified recombinant proteins are shown in Figure 1 (B). Minor amounts of a 40 kDa protein were also present in some of the 70 kDa preparations. This represents the 40 kDa gelatin-binding domain of fibronectin [38] , a frequent degradation product of the 70 kDa N-terminal fragment of fibronectin. Both the intact deletion mutants and the 40 kDa gelatin-binding domain cross-reacted with polyclonal antibodies to fibronectin in Western blots (results not shown).
RESULTS
Mutant 70 kDa proteins (
Recent evidence has shown that the 70 kDa N-terminal region of fibronectin can bind to conformationally altered III " module of fibronectin [22] or to a fusion protein containing III " and III # [27] . The binding site for the 70 kDa N-terminus of fibronectin could be exposed in the isolated III " module by heat denaturation of intact fibronectin, by proteolytic cleavage of fibronectin from the cell surface or treatment with dithiothreitol [22] . The binding site within the 70 kDa region for III " has been localized to the 27 kDa N-terminus, which contains five type I modules [22] . To further localize the III " binding site within the first five type I modules we tested the ability of the 70 kDa deletion mutants to bind to III " in solid-phase binding assays. levels of wild-type 70 kDa protein, suggesting that the III " binding site is contained within the I % and I & modules. The 70 kDa fragment has also been shown to bind to intact fibronectin after treatment with dithiothreitol [22] . Dithiothreitol treatment results in a 2.5-fold enhancement of 70 kDa binding, presumably by causing a conformational change in III " [22] . In results not shown, we examined binding of the 70 kDa protein and 70 kDa deletion mutants to untreated and dithiothreitol-treated fibronectin. As with the 70 kDa fragment, binding of the 70K∆I " -$ protein to dithiothreitol-treated fibronectin was enhanced 2.5-fold in comparison with untreated fibronectin, whereas binding of 70K∆I % -& mutant was low and similar to both types of fibronectin.
To confirm that 70K∆I " -$ contains a binding site for III " , competition binding experiments were performed. Figure 3 . These data demonstrate that binding of 70 kDa protein to heat-denatured III " is mediated by the fourth and fifth type I modules.
To determine whether I % and I & are both involved in binding to III "
, deletion mutants lacking I % or I & were tested in solid-phase binding assays using an ELISA assay. Figure 5 shows tested bound at levels comparable with intact 70 kDa protein ; binding ranged from 10 to 30 % of the levels of the wild-type protein.
In competition binding assays, the ability of various deletion mutants to inhibit binding of "#&I-fibronectin and "#&I-70 kDa to the cell surface was assessed. As shown in Figure 7 To determine if simultaneous addition of more than one deletion mutant results in competition similar to that seen with wild-type 70 kDa protein, 70K∆I " -$ and 70K∆I % -& were added together in competition binding assays. Figure 8 indicates that addition of both 70K∆I " -$ and 70K∆I % -& did not result in greater inhibition than that observed with 70K∆I " -$ alone. The competition curves would be dominated by the 70K∆I
To examine whether 70 kDa deletion mutants can also inhibit endogenous fibronectin matrix assembly, fibroblasts were seeded in the absence and presence of 500 nM intact 70 kDa protein or various deletion mutants in medium containing fibronectindepleted serum. Fibronectin fibrils polymerized by cells were revealed by indirect immunofluorescence. As shown in Figure 9 using 500 nM concentrations of 70 kDa constructs and "#&I-labelled fibronectin as shown in Figure 7 .
DISCUSSION
The present data indicate that polymerization of fibronectin into the extracellular matrix involves at least two cell-surface binding sites which interact with multiple sites within the 70 kDa Nterminus of fibronectin. Despite the efforts of numerous investigators to characterize the binding site on the cell surface for soluble fibronectin, identification has been elusive. Recent data have suggested the possibility that a conformationally altered III " module on cell-surface fibronectin may serve as an Nterminal binding site on the cell surface [22] , and that integrinmediated binding of fibronectin's III "! module to III " may cause a conformational change in III " [23] . In the present study we have used 70 kDa proteins lacking one or several type I modules to determine the role of individual type I modules in binding to fibroblasts and to fibronectin's III " module. The 70 kDa N-terminal region of fibronectin interacts with the surface of substrate-attached fibroblasts [13, 14] , Staphylococcus aureus [39] , fibrin [40, 41] and III " [22] . Previous studies using 70 kDa deletion mutants expressed in COS cells showed that all five type I modules were important for binding to fibroblasts and S. aureus, but that binding to fibrin appeared to be a general property of type I modules [28] . In the present study we show that binding of the 70 kDa N-terminus to fibronectin's III " module is localized predominantly to modules I % and I & . These data indicate that intermodule interactions between type I modules are necessary for the function of the N-terminal part of fibronectin. Little or no III " binding was detected in mutants lacking both I % and I & . 70K∆ " -$ was approx. 3-fold less effective at inhibiting "#&I-70kDa binding to heat-denatured III " than the intact 70 kDa protein. It is not unusual for smaller fragments of proteins to show alterations in activity when compared with the intact protein or to larger fragments. For example, the 27 kDa N-terminal fragment of fibronectin is 3-5-fold less effective in blocking "#&I-70 kDa binding to fibroblasts than is the 70 kDa fragment, even though the 40 kDa fragment does not directly participate in binding [13, 14] . Similarly, small peptides containing the Arg-Gly-Asp sequence in the tenth type III module of fibronectin are less effective in promoting cell adhesion than larger peptides or proteolytic fragments of fibronectin containing this sequence [42] . It is unlikely that the 40 kDa gelatin-binding region directly contributes to III " binding, since "#&I-labelled 40 kDa fragment could not be demonstrated to bind to heat denatured III " (Figure 4 ). In addition, Hocking et al. [22] showed that the 27 kDa and 70 kDa N-terminal fragments competed equally well for "#&I-70 kDa binding to heat-denatured III " . Taken together, these data demonstrate that all or most of the binding activity to III " is localized to I % and I & . The structures of single and tandem fibronectin type I modules have been analysed by NMR [43, 44] . The seventh type I module consists of two antiparallel β-sheets that are stacked on top of one another and which enclose a hydrophobic core containing conserved tyrosine and tryptophan residues and two disulphide bonds [43] . Structural analysis of two tandem type I modules, I % and I & , indicates that each module contains a compact structure with the same consensus fold as I ( [44] . Calorimetry studies also indicate that fibronectin type I modules are independently folded units [45] . Recently, tandem I % and I & modules produced in yeast [46] and bacteria [47, 48] were shown to retain the ability to bind to sequences on S. aureus [47] and to fibrin [46, 48] . Thus, even though structural studies indicate that type I modules fold independently, these modules can clearly interact to form functional domains critical for binding to III " , S. aureus and fibroblasts [28, 47 ; the present paper].
In the present study, the high-affinity binding site for fibroblasts could not be localized to I % and I & , consistent with previous data using 70 kDa deletion mutants produced in COS cells [28] . The inability to localize a binding site to one module in a multimodule array has also been described in other systems. Lipoproteins bind to the N-terminal region of the low-density lipoprotein (LDL) receptor, which contains seven cysteine-rich repeats. However, binding of the LDL receptor to LDL could not be localized to one cysteine-rich repeat, but was found to require repeats 3-7 [49] . Our data demonstrate that 70 kDa deletion mutants lacking I " -$ or I % -& bind specifically to the surface of fibroblasts at regions of focal adhesions. This is consistent with data showing that 70 kDa binding sites co-localize with α & β " integrins in focal adhesions [50] . Further, the ability of 70K∆I " -$ and 70K∆I % -& to partially inhibit "#&I-fibronectin binding and endogenous fibronectin matrix assembly suggests that these mutant proteins bind to sites on the cell surface that are involved in polymerization of fibronectin into the extracellular matrix.
These data provide the first evidence that more than one 70 kDa binding site may exist on the cell surface. The existence of two cell-surface sites that interact with different regions within type I modules 1-5 would explain the inability to localize the high-affinity fibroblast binding activity to specific type I modules (the present paper ; [28] ). Evidence that multiple binding sites may be present within the first five type I modules is also shown in Figure 7 , where 70K∆I " -$ and 70K∆I % -& were both able to compete partially for "#&I -fibronectin and 70 kDa binding to the cell surface. In addition, deletion mutants lacking two or more
Figure 10 Proposed model of fibronectin matrix assembly
The 70 kDa N-terminus of fibronectin interacts with an unidentified cell-surface protein (site 1, A), using modules I 1-3 or I [1] [2] [3] [4] [5] . Following this step, bound fibronectin is transferred from site 1 to site 2 on a growing fibronectin fibril. This interaction involves binding of I 4-5 to conformation-dependent site in the III 1 module on another cell-surface fibronectin molecule. It has been proposed that binding of fibronectin's III 10 module to the α 5 β 1 integrin may alter the conformation of III 1 , leading to exposure of a binding site for the N-terminus of fibronectin [23] .
modules competed more poorly for "#&I-fibronectin binding than mutants lacking single modules ( Figure 7A ). This may reflect the presence of multiple sites within the first five type I modules that can interact with the cell surface. If the second cell-surface binding site contains subsites for both I " -$ and I % -& then simultaneous addition of 70K∆I " -$ and 70K∆I % -& in competition binding assays with "#&I-fibronectin would not be expected to result in competition greater than that of 70K∆I " -$ alone ( Figure  8 ).
Our data suggest that one 70 kDa-cell surface interaction may involve binding of I % -& to the III " module on cell surface fibronectin (site 2, Figure 10 ). An additional interaction appears to involve the interaction of I " -& or I " -$ with an unidentified cellsurface protein (site 1, Figure 10 ). The striking effect of 70K∆I " -$ on elaboration of a fibrillar fibronectin matrix suggests that strong binding of I % -& to III " may occur after modules I " -& bind to this as-yet unidentified cell-surface receptor. These data are consistent with data showing that antibodies to III " block fibronectin binding to the cell surface in long-term assays, but do not block binding of the 70 kDa protein to the cell surface [25] or to heat-denatured III " [23] . In addition, these findings are consistent with the suggestion that the interaction of 70 kDa protein with III " occurs subsequent to the binding of the 70 kDa N-terminus to the cell surface [23, 25] .
We and others have proposed models for matrix assembly in which soluble fibronectin is assembled into disulfide stabilized aggregates in a stepwise fashion [23, 26, 27, 51, 52] . 
